Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case–control study

Analysis of a Japanese national database found 6 drug categories potentially associated with increased occurrence of drug-induced interstitial disease; highest odds ratios were for EGFR inhibitors (16.84, 95% CI 9.32 to 30.41) and class III antiarrhythmics (7.01, 3.86 to 12.73).

Source:

Thorax